Policy Update from AASLD President Saul J. Karpen & Hepatology Associate Representative, Dawn Drazek
AASLD recently submitted formal comments to the U.S. Department of Education opposing a proposed rule that would exclude nurse...
AASLD recently submitted formal comments to the U.S. Department of Education opposing a proposed rule that would exclude nurse...
The 2027 Spring Emerging Topic Conference will take place at the Four Seasons Hotel Las Vegas, Feb. 19–21, 2027. Stay informed...
AASLD’s Special Interest Groups (SIGs) are where ideas spark, collaborations begin, and advances in hepatology move forward.
We...
AASLD invites nominations to recognize leaders advancing hepatology; recipients will be honored at The Liver Meeting® 2026
ALEX...
As we recognize Rare Disease Month this February and Rare Disease Day on February 28, I’m reminded that in pediatric hepatology...
ALEXANDRIA, Virginia — A new study in HEPATOLOGY, the premier journal in the field of liver disease, reports that a noninvasive...
Alexandria, VA — The American Association for the Study of Liver Diseases (AASLD) announced the launch of its new Clinical...
Please note this event takes place in Denver and is scheduled in Mountain Time.
Organized by: Past President, W. Ray Kim and...
AASLD is committed to a new year of elevated opportunities, expanded impact, and continued leadership in hepatology. Through our advocacy, expertise, and commitment to innovation, we are shaping the future of hepatology and building on the momentum created by our dedicated leaders.
Active AASLD members are invited to submit a self or peer nomination for the 2027 Leadership Nominations cycle by March 1 at 11:59 p.m. EDT. Completed nomination applications will be due by March 18 at 11:59 p.m. EDT.